Farther Finance Advisors’s Sunshine Biopharma SBFM Stock Holding History

Farther Finance Advisors’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-1	Closed	-$2	–	6306
2026 Q2	$2	Buy	+1	New	+$6	﹤0.01%	5962
2026 Q1	–	Hold	0	–	–	–	5748
2025 Q4	–	Hold	0	–	–	–	5449
2025 Q3	–	Hold	0	–	–	–	4957
2025 Q2	–	Hold	0	–	–	–	4487
2025 Q1	–	Hold	0	–	–	–	4250
2024 Q4	–	Hold	0	–	–	–	3985
2024 Q3	–	Hold	0	–	–	–	3973

Farther Finance Advisors's SBFM Position: Q3 2026 in Review

Farther Finance Advisors sold out of Sunshine Biopharma (SBFM) in Q3 2026, closing a stake of 1 share — an estimated $2 sold.

Farther Finance Advisors first reported a position in SBFM in Q2 2026 and held it in 1 quarter. The position peaked at $2 in Q2 2026. 0 funds tracked by Wall St. Rank hold SBFM as of Q3 2026.

Farther Finance Advisors reported no remaining Sunshine Biopharma position as of Q3 2026 after selling out during the quarter.
Farther Finance Advisors sold 1 Sunshine Biopharma share in Q3 2026, an estimated $2.
Farther Finance Advisors first reported a position in Sunshine Biopharma in Q2 2026 and held it in 1 quarter.
Farther Finance Advisors's Sunshine Biopharma position peaked at $2 in Q2 2026.
0 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.